title: Should the FDA be the doctor of last resort?
authors.forename: Vincent T
authors.initials: VT
authors.lastname: DeVita
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003657:Decision Making; D017277:Drug Approval; D006801:Humans; D008495:Medical Oncology / Q000639:trends; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000970:Antineoplastic Agents